Family Medicine · Anaheim, CA
NPI
1588789218
Since 2007
Specialty
Family Medicine
Code 207Q00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
1125 N Magnolia Ave, Ste 115
Anaheim, CA, 92801
Phone (323) 921-6309
Groups this clinician bills Medicare through
Medicare paid, 2024
$527K
20,022 services
Medicare patients, 2024
512
Average age 74
Drug cost, 2024
$2.9M
17,796 prescriptions
Company payments, 2025
$4,004
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Herman B Bell was code J1100 (injection, dexamethasone sodium phosphate, 1 mg), 3,704 times for 221 patients. In total Herman B Bell billed 20,022 services in 92 codes, and Medicare paid $527K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-11-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 3,704 | 221 | $0.08 | $291 |
| 99213 Office E&M - Established | Office | 2,682 | 461 | $62.80 | $168K |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 2,130 | 210 | $0.32 | $679 |
| 96372 Injection Administration | Office | 1,755 | 351 | $10.19 | $18K |
| 81003 Clinical Chemistry | Office | 1,227 | 375 | $2.20 | $2,699 |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 1,108 | 155 | $0.45 | $496 |
| G0447 Face-to-face behavioral counseling for obesity, 15 minutes | Office | 1,016 | 227 | $24.37 | $25K |
| 82947 Clinical Chemistry | Office | 858 | 203 | $3.85 | $3,303 |
| 99212 Office E&M - Established | Office | 583 | 282 | $41.05 | $24K |
| 36415 Venipuncture Blood Collection | Office | 563 | 332 | $8.65 | $4,870 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 411 | 175 | $0.90 | $372 |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 314 | 314 | $19.18 | $6,023 |
| G0446 Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 298 | 298 | $24.38 | $7,264 |
| 99497 Care Management/Coordination | Office | 295 | 294 | $74.51 | $22K |
| 93000 Electrocardiogram | Office | 286 | 227 | $9.05 | $2,589 |
By year: 2022 $480K for 18,915 services; 2023 $529K for 21,334 services; 2024 $527K for 20,022 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 1,227 | 375 | $2.20 | $2,699 |
| 82947 Clinical Chemistry | 858 | 203 | $3.85 | $3,303 |
| 36415 Venipuncture Blood Collection | 563 | 332 | $8.65 | $4,870 |
| 0241U Infectious Agent Detection by DNA/RNA | 232 | 156 | $139.78 | $32K |
Medicare prescription drug claims, 2024
In 2024, the drug Herman B Bell prescribed most often to Medicare patients was Amlodipine Besylate, with 611 prescriptions and refills. In total Herman B Bell wrote 17,796 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 611 | 853 | 110 | $694 |
| Gabapentin Generic | 555 | 655 | 106 | $1,771 |
| Diclofenac Sodium Generic | 544 | 596 | 112 | $198K |
| Nabumetone Generic | 481 | 687 | 152 | $5,998 |
| Jardiance Empagliflozin | 408 | 516 | 75 | $293K |
| Kerendia Finerenone | 400 | 451 | 69 | $284K |
| Tamsulosin Hcl Generic | 390 | 518 | 74 | $1,641 |
| Benazepril Hcl Generic | 384 | 565 | 71 | $1,363 |
| Atorvastatin Calcium Generic | 361 | 495 | 66 | $1,088 |
| Omeprazole Generic | 360 | 465 | 84 | $1,031 |
| Losartan Potassium Generic | 358 | 531 | 62 | $1,036 |
| Levothyroxine Sodium Generic | 347 | 467 | 53 | $1,930 |
| Pioglitazone Hcl Generic | 343 | 417 | 54 | $947 |
| Dexlansoprazole Dr Dexlansoprazole | 309 | 348 | 57 | $61K |
| Metformin Hcl Generic | 296 | 464 | 75 | $591 |
Brand drugs: 3,697 claims; generic drugs: 13,896 claims; opioid claims: 79.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Herman B Bell $4,004 ($4,004 in general payments such as food, travel and fees) from 17 companies. The largest payer was Amgen Inc. with $1,232.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 20 | $1,232 |
| Abbvie Inc. ABBV | 6 | $538 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 13 | $385 |
| Sumitomo Pharma America, Inc. 4506.T | 19 | $340 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 7 | $336 |
| Lundbeck LLC | 14 | $230 |
| Mannkind Corporation MNKD | 11 | $187 |
| Lilly USA, LLC LLY | 3 | $171 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 8 | $151 |
| Novo Nordisk Inc NVO | 2 | $135 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.